XML 125 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activities

The following table summarizes stock option activities for the years ended December 31, 2024 and 2023:

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted Average

​

​

​

​

​

​

​

Remaining

​

​

​

​

Weighted Average

​

Contractual Life (in

​

​

Stock Options

​

Exercise Price

​

years)

Outstanding at December 31, 2023

 

1,521

​

$

4,297.50

 

3.31

Outstanding at December 31, 2024

 

1,521

​

$

4,297.50

 

2.31

Options vested and exercisable at December 31, 2024

 

951

​

$

4,297.50

 

2.31

Schedule of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense for the years ended December 31, 2024 and 2023 (in thousands).

​

​

​

​

​

​

​

​

​

​

​

For the year ended December 31, 

​

​

    

2024

    

2023

    

General and administrative

​

$

200

​

$

436

​

Research and development

​

 

(650)

​

 

132

​

Total stock-based compensation expense

​

$

(450)

​

$

568

​

Summary of Warrant Activities

A summary of warrant activities for the years ended December 31, 2024 and 2023, is presented below:

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted Average

​

​

​

​

​

​

​

Remaining

​

​

​

​

Weighted Average

​

Contractual Life (in

​

​

Warrants

​

Exercise Price

​

years)

Outstanding as of December 31, 2022

 

1,387

​

$

1,152.94

 

8.29

Expired

​

(1)

​

​

0.08

​

—

Granted

 

88,232

​

 

50.09

 

5.29

Outstanding as of December 31, 2023

 

89,618

​

$

67.16

 

5.34

Exercised

 

(747,368)

​

 

5.35

 

—

Granted

 

2,234,669

​

 

10.93

 

2.10

Outstanding as of December 31, 2024

 

1,576,919

​

$

14.56

 

3.14

Schedule of key inputs used for the Black-Scholes Model calculation to measure the fair value the New Warrants

The key inputs used for the Black-Scholes Model calculation on October 25, 2024, to measure the fair value of the New Warrants, were as follows:

​

​

​

​

​

​

​

​

​

​

New Series B-1

​

New Series B-2

​

​

Warrants

​

Warrants

Stock Price

​

14.50

​

​

14.50

​

Risk-free interest rate

​

4.1

%

​

4.3

%

Expected dividend yield

​

—

​

​

—

​

Expected term in years

​

5

​

​

1

​

Expected volatility

​

122.2

%

​

213.2

%

Restricted stock award  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

Certain employees and directors have been awarded restricted stock. The restricted stock vesting consists of milestone and time-based vesting. The following table summarizes restricted stock award activities for the years ended December 31, 2024 and 2023:

​

​

​

​

​

​

​

​

    

​

    

Weighted Average

​

​

​

​

Grant Date Fair

​

​

Number of Shares

​

Value

Nonvested at December 31, 2022

 

675

​

$

1,107.83

Granted

​

720

​

​

345.00

Vested

​

(110)

​

​

2,310.00

Nonvested at December 31, 2023

 

1,285

​

$

577.50

Vested

​

(90)

​

​

2,722.50

Nonvested at December 31, 2024

 

1,195

​

$

415.95

Restricted stock units  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

The following table summarizes restricted stock units’ activities for the year ended December 31, 2024 and 2023:

​

​

​

​

​

​

​

​

    

​

    

Weighted Average

​

​

​

​

Grant Date Fair

​

​

Number of Units

​

Value

Nonvested at December 31, 2022

 

3,303

​

$

1,391.48

Granted

 

577

​

 

256.51

Forfeited

​

(1,027)

​

​

1,374.25

Vested

​

(942)

​

​

1,614.25

Nonvested at December 31, 2023

 

1,911

​

$

948.25

Forfeited

​

(1,320)

​

​

911.70

Vested

 

(365)

​

 

1,205.20

Nonvested at December 31, 2024

 

226

​

$

746.70